Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with heart failure that causes symptoms.
- People whose heart is pumping at 40% or less of its normal capacity (a condition called heart failure with reduced ejection fraction), confirmed by a heart scan taken within the last 6 months or earlier if results are available.
- People who already have a cardiac resynchronisation therapy (CRT) device implanted, provided it was put in more than 1 year ago and their heart failure symptoms are classified as severe (NYHA Class III or IV) (confirm with trial site).
Who may not be able to join:
- People who are considered unlikely to follow their prescribed medical treatment, for reasons other than side effects or medical reasons why a treatment cannot be used.
- People with a QMS score above 5 — this is a specific measurement used by the trial team (confirm with trial site for details).
- People whose kidneys are functioning below a certain level (an eGFR reading below 15).
- People who already have a CRT device implanted and whose heart has responded well to that device.
- People for whom a CRT device is already strongly recommended as a first-line treatment under medical guidelines.
- People with other serious health conditions that may affect the trial's assessments or results.
- People who have medical reasons preventing them from receiving the study's treatment (CCM therapy) or from having a device implanted.
- People with severe narrowing of one or more heart valves.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (856) 642-9933
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Quad Medication Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.